Navigation Links
CSA Medical, Inc. Announces Launch of New Web Site for Spray Cryotherapy
Date:3/16/2009

BALTIMORE, March 16 /PRNewswire/ -- CSA Medical, Inc., manufacturer of the CryoSpray Ablation system, announced today the official launch of its newly redesigned Web site (www.CSAmedical.com).

(Logo: http://www.newscom.com/cgi-bin/prnh/20080721/NEM114LOGO )

The Web site features information about Spray Cryotherapy, the patented technology platform that allows physicians to deliver supercool liquid nitrogen spray to freeze and destroy unwanted tissue in the body. The updated site offers patients and physicians more insight about the CryoSpray Ablation procedure and its benefits, and helps patients locate the 70+ medical institutions that offer Spray Cryotherapy.

"This new Web site was designed specifically for our online audience of patients and their families, and the physicians who can help them," says Richard Hughen, VP of Sales and Marketing of CSA Medical. In addition to patient and physician testimonials, the site offers visitors a view of what to expect, whether as a recipient or provider of Spray Cryotherapy treatment. Users can also access video clips to better understand how the treatment is delivered. "The redesigned site is an important part of our mission to accelerate the adoption and use of this versatile technology," adds Hughen. This FDA-cleared device has been used by physicians on a wide range of endoscopic applications to "freeze the disease and free the patient."

About CSA Medical, Inc:

CSA Medical has advanced the proven science of cryotherapy. With the CryoSpray Ablation System, physicians have the ability to quickly and easily freeze, destroy and remove unwanted tissue, freeing patients from the discomfort and worry. The CryoSpray Ablation system uses a patented technology to deliver liquid nitrogen through a cathete
'/>"/>

SOURCE CSA Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. China Sky One Medical, Inc. Obtains SFDA Approval for Policresulen Vaginal Suppositories
2. Solta Medical, Inc. Secures $9M Credit Facility from Silicon Valley Bank
3. Solta Medical, Inc. Announces State-of-the-Art Aesthetic Center
4. China Sky One Medical, Inc. Exports Sumei Slim Patch to South Korea and Sudan
5. China Sky One Medical, Inc. Reaffirms Guidance for 2008 Revenue and Net Income and Provides Business Update
6. Solta Medical, Inc. Announces Preliminary Financial Results for the Fourth Quarter of 2008
7. Nonin Medical, Inc. Makes History With the First Continua(TM) Certified Product
8. Insightra Medical, Inc. Gains FDA clearance for the Most Complete Range of 7Fr Intra Aortic Balloon (IAB) Catheters
9. China Sky One Medical, Inc. Provides Business Update
10. Thermage, Inc. Announces Name Change to Solta Medical, Inc.
11. China Sky One Medical, Inc. Obtains Production Rights for Two Additional Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... Florida (PRWEB) November 21, 2014 Nature’s Sleep is ... Sleep contest . The contest calls for the creation of any ... a photo — that encompasses sleep, a bed or a mattress. ... year,” said Alan Hirschhorn, Vice President of Marketing for Nature’s Sleep, ... an array of more than 10,000 creative entries from some very ...
(Date:11/21/2014)... HealthDay Reporter THURSDAY, Nov. 20, 2014 ... of a still-beating heart has the potential to improve the ... new study. Heart patients who received the gel implant ... hundreds of feet farther during a six-minute walk test, said ... cardiovascular division at Washington University School of Medicine and a ...
(Date:11/21/2014)... HealthDay Reporter THURSDAY, Nov. ... excess or binge drink are not alcoholics, a new U.S. ... who drink too much aren,t dependent on alcohol. But one ... Centers for Disease Control and Prevention. , , "A lot of ... alcoholics," said study co-author Dr. Robert Brewer, the leader of ...
(Date:11/18/2014)... November 18, 2014 Cristcot Inc., ... development and commercialization of specialized drug delivery systems, ... granted Cristcot a patent for the technology, which ... Sephure®. , The patent was awarded to ... rights have been assigned to Cristcot Inc. The ...
(Date:11/18/2014)... HealthDay Reporter MONDAY, ... cholesterol down to extremely low levels with a combination ... in high-risk patients with clogged arteries, a new study ... when taking Vytorin, a drug that combines a cholesterol-lowering ... said principal investigator Dr. Christopher Cannon, a cardiologist at ...
Breaking Medicine News(10 mins):Health News:Nature’s Sleep Kicks Off their 2nd Art Of Sleep Contest 2Health News:Gel Implant Might Help Fight Heart Failure 2Health News:Gel Implant Might Help Fight Heart Failure 3Health News:Many People Who Drink a Lot Aren't Alcoholics: CDC 2Health News:Many People Who Drink a Lot Aren't Alcoholics: CDC 3Health News:Japanese Patent Office Grants Patent to Cristcot Inc. 2Health News:Cholesterol Drug Vytorin Linked to Reduced Heart Attack Risk 2Health News:Cholesterol Drug Vytorin Linked to Reduced Heart Attack Risk 3
... HARRISBURG, Pa. , Sept. 8 ... for subsidized health insurance coverage, state Insurance Commissioner Joel Ario today urged ... that will give Pennsylvania and other states tools needed to fix the ... , "Lost in the din of the recent town hall ...
... Delta Health , an InfoLogix, ... that it has been selected by Hennepin County Medical Center in ... impact margins through productivity management. , , (Logo: ... , Delta Health has helped hospitals across North America ...
... , NEW YORK, Sept. 8 /PRNewswire-FirstCall/ - (OTCBB: GVBP.OB) ... that it has filed a patent for a novel ... thus has blockbuster potential as a new anti-cancer drug. ... which is highly reactive to prostate cancer cells, and ...
... Sept. 8 MRSA Survivors Network, the Chicago-based nonprofit and official ... lift the veil of secrecy surrounding MRSA. The history making ... October 1st. The 2009 theme is "You Can Not Change What ... http://www.newscom.com/cgi-bin/prnh/20090825/DC65136LOGO ) , , Founder ...
... , NEW YORK, Sept. 8 NeoStem, ... pioneering the pre-disease collection, processing and long-term storage of adult stem ... Robin Smith, M.D., MBA, will present on the Company,s latest strategic ... New York Palace Hotel in New York City on September 9-11, ...
... , , WALTHAM, Mass., ... the global authority on medical technology market intelligence, the ... experience considerable growth in sales over the next five ... 2009 report finds, however, that product safety issues ...
Cached Medicine News:Health News:Insurance Commissioner Says Federal Health Care Reform Necessary to Fix a Broken System 2Health News:Delta Health, an InfoLogix Company, Wins Engagement with Hennepin County Medical Center for Strategic Cost Management 2Health News:Delta Health, an InfoLogix Company, Wins Engagement with Hennepin County Medical Center for Strategic Cost Management 3Health News:Genova files patent for new prostate cancer treatment 2Health News:MRSA Activists to Lift the Veil of Secrecy on World MRSA Day 2Health News:NeoStem to Present at Rodman & Renshaw's 11th Annual Healthcare Conference 2Health News:NeoStem to Present at Rodman & Renshaw's 11th Annual Healthcare Conference 3Health News:Will the FDA Ban Hydroquinone in Pigment Control Products? 2Health News:Will the FDA Ban Hydroquinone in Pigment Control Products? 3
(Date:11/21/2014)... QC , Nov. 20, 2014 /CNW Telbec/ - ... to announce the following appointments: ... team in the newly created role of Chief Commercial ... BioPhotonic system using topical photoconverter gel for the treatment ... surgical and traumatic wounds, recently approved in ...
(Date:11/21/2014)... 20, 2014 Depomed, Inc. (NASDAQ: DEPO ) ... 26 th Annual Healthcare Conference in New York ... conference is scheduled for 8:00 am EST (5:00 am PST) on ... webcast can be accessed via the Investor Relations page of the ... will be archived for 30 days on the company,s website. ...
(Date:11/21/2014)... 2014   Wellcentive , the industry leader ... organizations, announced today being named one of the ... Award .  Sponsored by Intel, the world leader ... year, recognizes companies developing leading-edge technology and unique ... Wellcentive,s Mason Beard , ...
Breaking Medicine Technology:KLOX Technologies announces executive appointments 2KLOX Technologies announces executive appointments 3KLOX Technologies announces executive appointments 4Depomed To Present At Piper Jaffray 26th Annual Healthcare Conference 2Wellcentive Named Finalist for 2014 Intel Innovation Award 2Wellcentive Named Finalist for 2014 Intel Innovation Award 3
... Launches 1,000-Patient Lung Cancer Diversity Study, CHICAGO, June ... the leading cause of cancer death in,African-Americans, with ... deaths expected this year.(i) Equally devastating, lung,cancer is ... men and the,second leading cause of cancer death ...
... an overall CBR of 52% which compares ... CITY, QC, June 04, 2007 /PRNewswire-FirstCall/ - ... focused on,endocrine therapy and oncology, today announced ... outlining Phase 1 and,Phase 2 results for ...
Cached Medicine Technology:Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 2Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 3Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 4Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 5Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 6Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 7Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 8Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 9Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 10Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 11AEterna Zentaris Partner Keryx Presents Phase 1 and Phase 2 Results,for Anti-Cancer Compound Perifosine at ASCO Meeting 2AEterna Zentaris Partner Keryx Presents Phase 1 and Phase 2 Results,for Anti-Cancer Compound Perifosine at ASCO Meeting 3AEterna Zentaris Partner Keryx Presents Phase 1 and Phase 2 Results,for Anti-Cancer Compound Perifosine at ASCO Meeting 4
... MedPoint™, a Medication Administration Control System, ... assurance that they are administering the ... used with a bar coded patient ... extends the benefits of the hospital's ...
... MediMAR™ is the newest Mediware ... medication administration record. MediMAR produces a ... patient's medication profile, including clinician orders, ... to medication administration or alerts that ...
... When it comes to medication administration, ... afford to make. The solution is the ... a highly-scalable bar-coded medication administration system, suitable ... also be used stand-alone, networked, or as ...
... Outlook® Safety Infusion System is designed to ... drug, and the right dose. Available in ... Outlook® Safety Infusion System allows hospitals to ... meet their needs. DoseGuard™ dose limit technology ...
Medicine Products: